AC
AGIO icon

Amia Capital’s Agios Pharmaceuticals AGIO Stock Holding History

Amia Capital’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,740
Closed -$761K – 7
2020
Q3 		$761K Sell
21,740
-356
-2% -$15.6K 0.88% 17
2020
Q2 		$1.18M Sell
22,096
-11,862
-35% -$549K 0.97% 15
2020
Q1 		$1.21M Sell
33,958
-5,312
-14% -$245K 1.07% 15
2019
Q4 		$1.88M Buy
+39,270
New +$1.48M 0.55% 18

Other funds holding AGIO

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Amia Capital's AGIO Position: Q4 2020 in Review

Amia Capital sold out of Agios Pharmaceuticals (AGIO) in Q4 2020, closing a stake of 21,740 shares — an estimated $761K sold.

Amia Capital first reported a position in AGIO in Q4 2019 and held it in 4 quarters. The position peaked at $1.88M in Q4 2019. 200 funds tracked by Wall St. Rank hold AGIO as of Q4 2020.

  • Amia Capital reported no remaining Agios Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Amia Capital sold 21,740 Agios Pharmaceuticals shares in Q4 2020, an estimated $761K.
  • Amia Capital first reported a position in Agios Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Amia Capital's Agios Pharmaceuticals position peaked at $1.88M in Q4 2019.
  • 200 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q4 2020.

Based on Amia Capital's 13F filing for Q4 2020, filed 11 Feb 2021.